Switching from therapy with typical antipsychotic agents to risperidone: Long-term impact on patient outcome
β Scribed by Ashok K. Malla; Ross M.G. Norman; Vinod Kotteda; Sandra Zirul
- Book ID
- 117322300
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 853 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0149-2918
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to longβacting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirtyβsix patients with schizophrenia treated with oral
## Abstract ## Objective This international, nonβrandomised study evaluated maintained efficacy and safety of Risperidone LongβActing Injectable (RLAI) compared to previous medications. To investigate the possible effect of differences in national health care systems across Europe, the UK subset e